Liyuan Yao

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Lysine Methyltransferases SMYD2 and SMYD3: Emerging Targets in Kidney Diseases”.

Lysine Methyltransferases SMYD2 and SMYD3: Emerging Targets in Kidney Diseases

Kidney Diseases(2025)10.1159/000547202

N/A

0DataRank · unranked

1 citations

Liyuan Yao, Shougang Zhuang, Xinyu Du

Genetic depletion or pharmacological degradation of EZH2 attenuates renal fibrosis via suppressing Notch signaling

Clinical Epigenetics(2025)10.1186/s13148-025-02013-9

N/A

0DataRank · unranked

1 citations

Liyuan Yao, Xinyu Du, Jianjun Yu, Yanjin Wang, Xiying Hou +4 more

HDAC11 promotes renal fibrosis by induing partial epithelial-mesenchymal transition and G2/M phase arrest in renal epithelial cells

Research Square(2025)10.21203/rs.3.rs-6523050/v1

N/A

0DataRank · unranked

0 citations

Fengchen Shen, Liyuan Yao, Ting C. Zhao, Shougang Zhuang, Yingjie Guan

HDAC4 drives ferroptosis and fibrosis by inhibiting Foxo3a-GPX4 axis during AKI–CKD progression

Research Square(2025)10.21203/rs.3.rs-7809768/v1

N/A

0DataRank · unranked

0 citations

Xinyu Du, Liyuan Yao, Chao Yu, Yanjin Wang, Jianjun Yu +5 more

HDAC11 promotes renal fibrosis by induing partial epithelial-mesenchymal transition and G2/M phase arrest in renal epithelial cells

Molecular Medicine(2025)10.1186/s10020-025-01367-3

N/A

0DataRank · unranked

0 citations

Fengchen Shen, Liyuan Yao, Meiying Chang, Ting C. Zhao, Shougang Zhuang +1 more